SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

DRI Healthcare Reports Third-Quarter 2026 Results

Normalized Total Cash Receipts and Adjusted EBITDA each grew 9%, to $47.5 million and $40.0 million, respectively.

Related stories